Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
54m agoAshram Project Fluorspar Development Update
55m agoThink 2026: IBM Delivers the Blueprint for the AI Operating Model as the AI Divide Widens
55m agoThink 2026: IBM Makes Digital Sovereignty Operational with General Availability of IBM Sovereign Core
1h agoProPetro Holding Corp. Prices Upsized $600 Million Convertible Senior Notes Offering
1h agoBunker Hill Mining on Track for June Restart of Operations
Ocular Therapeutix, Inc. logo

Ocular Therapeutix, Inc.

About

Ocular Therapeutix, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 29 2026
Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD
Apr 28 2026
Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026
Apr 27 2026
Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences
Apr 22 2026
Ocular Therapeutix™ to Host Investor Day on June 17, 2026
Apr 13 2026
Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD
Case study
How Ocular Therapeutix, Inc. runs its investor program on 6ix — audience, formats, and program overview.

Community Chat

Ask AI

6ix6ix